Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Non-invasive diagnosis of patients with 'at-risk' NAFLD : only fibrosis counts?

Geier A, Boursier J.

Gut. 2020 Mar 27. pii: gutjnl-2020-320785. doi: 10.1136/gutjnl-2020-320785. [Epub ahead of print] No abstract available.

PMID:
32220903
2.

Sleep Duration Is Associated with Academic Achievement of Adolescent Girls in Mathematics.

Lin L, Somerville G, Boursier J, Santisteban JA, Gruber R.

Nat Sci Sleep. 2020 Feb 24;12:173-182. doi: 10.2147/NSS.S237267. eCollection 2020.

3.

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.

Newsome PN, Sasso M, Deeks JJ, Paredes A, Boursier J, Chan WK, Yilmaz Y, Czernichow S, Zheng MH, Wong VW, Allison M, Tsochatzis E, Anstee QM, Sheridan DA, Eddowes PJ, Guha IN, Cobbold JF, Paradis V, Bedossa P, Miette V, Fournier-Poizat C, Sandrin L, Harrison SA.

Lancet Gastroenterol Hepatol. 2020 Apr;5(4):362-373. doi: 10.1016/S2468-1253(19)30383-8. Epub 2020 Feb 3. Erratum in: Lancet Gastroenterol Hepatol. 2020 Apr;5(4):e3.

4.

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.

Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators.

Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5.

PMID:
31813633
5.

Obstructive sleep apnoea severity and liver steatosis measured by magnetic resonance imaging.

Trzepizur W, Boursier J, Berréhare A, Le Vaillant M, Andriantsitohaina R, Ducluzeau PH, Dubois S, Henni S, Abraham P, Calès P, Aubé C, Paisant A, Gagnadoux F; on the behalf of the METABOL group.

Eur Respir J. 2020 Jan 9;55(1). pii: 1901514. doi: 10.1183/13993003.01514-2019. Print 2020 Jan. No abstract available.

PMID:
31649063
6.

Ethanol Extract of Leaves of Cassia siamea Lam Protects against Diabetes-Induced Insulin Resistance, Hepatic, and Endothelial Dysfunctions in ob/ob Mice.

Koffi C, Soleti R, Nitiema M, Mallegol P, Hilairet G, Chaigneau J, Boursier J, Kamagate M, Le Lay S, Die-Kakou HM, Andriantsitohaina R.

Oxid Med Cell Longev. 2019 Sep 17;2019:6560498. doi: 10.1155/2019/6560498. eCollection 2019.

7.

Direct comparison of the specialised blood fibrosis tests FibroMeterV2G and Enhanced Liver Fibrosis score in patients with non-alcoholic fatty liver disease from tertiary care centres.

Guillaume M, Moal V, Delabaudiere C, Zuberbuhler F, Robic MA, Lannes A, Metivier S, Oberti F, Gourdy P, Fouchard-Hubert I, Selves J, Michalak S, Peron JM, Cales P, Bureau C, Boursier J.

Aliment Pharmacol Ther. 2019 Dec;50(11-12):1214-1222. doi: 10.1111/apt.15529. Epub 2019 Oct 15.

PMID:
31617224
8.

Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study.

Wargny M, Smati S, Pichelin M, Bigot-Corbel E, Authier C, Dierry V, Zaïr Y, Jacquin V, Hadjadj S, Boursier J, Cariou B.

PLoS One. 2019 Aug 29;14(8):e0221524. doi: 10.1371/journal.pone.0221524. eCollection 2019.

9.

Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients.

Broussier T, Lannes A, Zuberbuhler F, Oberti F, Fouchard I, Hunault G, Cales P, Boursier J.

Clin Res Hepatol Gastroenterol. 2019 Aug 14. pii: S2210-7401(19)30175-5. doi: 10.1016/j.clinre.2019.07.010. [Epub ahead of print]

PMID:
31422033
10.

Noninvasive Tests of Liver Fibrosis and Their Combination in Nonalcoholic Fatty Liver Disease: From Selected Patients to Real-Life Populations.

Boursier J, Francque S.

Hepatology. 2019 Nov;70(5):1500-1502. doi: 10.1002/hep.30886. No abstract available.

PMID:
31381156
11.

Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.

Ampuero J, Pais R, Aller R, Gallego-Durán R, Crespo J, García-Monzón C, Boursier J, Vilar E, Petta S, Zheng MH, Escudero D, Calleja JL, Aspichueta P, Diago M, Rosales JM, Caballería J, Gómez-Camarero J, Lo Iacono O, Benlloch S, Albillos A, Turnes J, Banales JM, Ratziu V, Romero-Gómez M; HEPAmet Registry.

Clin Gastroenterol Hepatol. 2020 Jan;18(1):216-225.e5. doi: 10.1016/j.cgh.2019.05.051. Epub 2019 Jun 11.

PMID:
31195161
12.

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.

Boursier J, Guillaume M, Leroy V, Irlès M, Roux M, Lannes A, Foucher J, Zuberbuhler F, Delabaudière C, Barthelon J, Michalak S, Hiriart JB, Peron JM, Gerster T, Le Bail B, Riou J, Hunault G, Merrouche W, Oberti F, Pelade L, Fouchard I, Bureau C, Calès P, de Ledinghen V.

J Hepatol. 2019 Aug;71(2):389-396. doi: 10.1016/j.jhep.2019.04.020. Epub 2019 May 16.

PMID:
31102719
13.

Noninvasive diagnosis of liver fibrosis in NAFLD: Tips tricks.

Zuberbuhler F, Boursier J.

Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):658-662. doi: 10.1016/j.clinre.2019.03.009. Epub 2019 Apr 24.

PMID:
31029645
14.

Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!

Berger A, Shili S, Zuberbuhler F, Hiriart JB, Lannes A, Chermak F, Hunault G, Foucher J, Oberti F, Fouchard-Hubert I, Cales P, de Ledinghen V, Boursier J.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00023. doi: 10.14309/ctg.0000000000000023.

15.

Obstructive sleep apnoea and non-alcoholic fatty liver disease: Which patients should be referred to hepatologists?

Gagnadoux F, Boursier J, Calès P, Trzepizur W.

Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):e90-e92. doi: 10.1016/j.clinre.2019.02.013. Epub 2019 Mar 29. No abstract available.

PMID:
30935907
16.

Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid.

Coué M, Tesse A, Falewée J, Aguesse A, Croyal M, Fizanne L, Chaigneau J, Boursier J, Ouguerram K.

Nutrients. 2019 Jan 18;11(1). pii: E194. doi: 10.3390/nu11010194.

17.

Phenotyping of circulating extracellular vesicles (EVs) in obesity identifies large EVs as functional conveyors of Macrophage Migration Inhibitory Factor.

Amosse J, Durcin M, Malloci M, Vergori L, Fleury A, Gagnadoux F, Dubois S, Simard G, Boursier J, Hue O, Martinez MC, Andriantsitohaina R, Le Lay S.

Mol Metab. 2018 Dec;18:134-142. doi: 10.1016/j.molmet.2018.10.001. Epub 2018 Oct 9.

18.

Doppler ultrasonography devices, including elastography, allow for accurate diagnosis of severe liver fibrosis.

Delahaye J, Bazeries P, Lannes A, Lebigot J, Cartier V, Oberti F, Fouchard-Hubert I, Paisant A, Michalak-Provost S, Rousselet MC, Cales P, Boursier J, Aubé C.

Eur J Radiol. 2018 Nov;108:133-139. doi: 10.1016/j.ejrad.2018.09.019. Epub 2018 Sep 19.

PMID:
30396646
19.

Reproducibility, Accuracy and Effect of Autoclave Sterilization on a Thermoplastic Three-Dimensional Model Printed by a Desktop Fused Deposition Modelling Three-Dimensional Printer.

Boursier JF, Fournet A, Bassanino J, Manassero M, Bedu AS, Leperlier D.

Vet Comp Orthop Traumatol. 2018 Nov;31(6):422-430. doi: 10.1055/s-0038-1668113. Epub 2018 Oct 9.

PMID:
30300914
20.

Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter Western study.

Berger A, Rahmi G, Perrod G, Pioche M, Canard JM, Cesbron-Métivier E, Boursier J, Samaha E, Vienne A, Lépilliez V, Cellier C.

Endoscopy. 2019 Apr;51(4):298-306. doi: 10.1055/a-0732-5317. Epub 2018 Sep 27.

PMID:
30261535
21.

Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population.

Wargny M, Ducluzeau PH, Petit JM, Le May C, Smati S, Arnaud L, Pichelin M, Bouillet B, Lannes A, Blanchet O, Lefebvre P, Francque S, Van Gaal L, Staels B, Vergès B, Boursier J, Cariou B.

Atherosclerosis. 2018 Nov;278:82-90. doi: 10.1016/j.atherosclerosis.2018.09.008. Epub 2018 Sep 13.

PMID:
30261472
22.

Ultrasonography is more accurate than percutaneous palpation for identifying targeted thoracolumbar intervertebral disc spaces in dogs.

Boursier JF, Fournet A, Bassanino J, Manassero M, Bedu AS, Leperlier D.

Vet Radiol Ultrasound. 2018 Nov;59(6):749-757. doi: 10.1111/vru.12672. Epub 2018 Jul 29.

PMID:
30058090
23.

Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.

Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, Stärkel P, Gyune Kim S, Fernandez M, Madsen B, Naveau S, Krag A, Perlemuter G, Ziol M, Chatelain D, Diouf M.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):614-625. doi: 10.1016/S2468-1253(18)30124-9. Epub 2018 Jul 6.

PMID:
29983372
24.

Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities.

Trzepizur W, Boursier J, Le Vaillant M, Ducluzeau PH, Dubois S, Henni S, Abraham P, Aubé C, Calès P, Gagnadoux F; on the behalf of the METABOL group.

Eur Respir J. 2018 Jun 28;51(6). pii: 1800601. doi: 10.1183/13993003.00601-2018. Print 2018 Jun.

25.

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.

Corpechot C, Chazouillères O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, Goria O, Potier P, Minello A, Silvain C, Abergel A, Debette-Gratien M, Larrey D, Roux O, Bronowicki JP, Boursier J, de Ledinghen V, Heurgue-Berlot A, Nguyen-Khac E, Zoulim F, Ollivier-Hourmand I, Zarski JP, Nkontchou G, Lemoinne S, Humbert L, Rainteau D, Lefèvre G, de Chaisemartin L, Chollet-Martin S, Gaouar F, Admane FH, Simon T, Poupon R.

N Engl J Med. 2018 Jun 7;378(23):2171-2181. doi: 10.1056/NEJMoa1714519.

26.

Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.

Boursier J, Cassinotto C, Hunault G, Shili S, Lebigot J, Lapuyade B, Lannes A, Hiriart JB, Cartier V, Le Bail B, Michalak S, Mouries A, Oberti F, Chermak F, Fouchard-Hubert I, Cales P, Aube C, de Ledinghen V.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):164-171.e5. doi: 10.1016/j.cgh.2018.04.062. Epub 2018 May 9.

PMID:
29753082
27.

A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis.

Calès P, Boursier J, Oberti F, Moal V, Fouchard Hubert I, Bertrais S, Hunault G, Rousselet MC; multicentric groups (SNIFF, ANRS HC 23).

Hepatol Commun. 2018 Mar 5;2(4):455-466. doi: 10.1002/hep4.1161. eCollection 2018 Apr.

28.

Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH.

Boursier J, Anty R, Vonghia L, Moal V, Vanwolleghem T, Canivet CM, Michalak S, Bonnafous S, Michielsen P, Oberti F, Iannelli A, Van Gaal L, Patouraux S, Blanchet O, Verrijken A, Gual P, Rousselet MC, Driessen A, Hunault G, Bertrais S, Tran A, Calès P, Francque S.

Aliment Pharmacol Ther. 2018 May;47(10):1387-1396. doi: 10.1111/apt.14621. Epub 2018 Mar 25.

29.

Effectiveness of a bipolar vessel sealant device for ovariohysterectomy in cats with pyometra.

Boursier JF, Bassanino J, Leperlier D.

J Feline Med Surg. 2018 Dec;20(12):1119-1123. doi: 10.1177/1098612X17752581. Epub 2018 Jan 23.

PMID:
29359610
30.

Stabilization of Olecranon Fractures by Tension Band Wiring or Plate Osteosynthesis: A Retrospective Study of 41 Cases.

Fournet A, Boursier JF, Corbeau S, Decambron A, Viateau V, Fayolle P, Bedu AS, Leperlier D, Manassero M.

Vet Comp Orthop Traumatol. 2018 Jan;31(1):53-61. doi: 10.1160/VCOT-17-04-0057. Epub 2018 Jan 11.

PMID:
29325193
31.

Reply to: "Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FMVCTE algorithm" and to "Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes".

Boursier J, de Ledinghen V, Leroy V, Calès P.

J Hepatol. 2018 Mar;68(3):605-606. doi: 10.1016/j.jhep.2017.09.022. Epub 2017 Oct 4. No abstract available.

PMID:
28987517
32.

Estrogen receptor α/HDAC/NFAT axis for delphinidin effects on proliferation and differentiation of T lymphocytes from patients with cardiovascular risks.

Dayoub O, Le Lay S, Soleti R, Clere N, Hilairet G, Dubois S, Gagnadoux F, Boursier J, Martínez MC, Andriantsitohaina R.

Sci Rep. 2017 Aug 24;7(1):9378. doi: 10.1038/s41598-017-09933-4.

33.

Large oesophageal varice screening by a sequential algorithm using a cirrhosis blood test and optionally capsule endoscopy.

Calès P, Sacher-Huvelin S, Valla D, Bureau C, Olivier A, Oberti F, Boursier J, Galmiche JP; multicenter group VO-VCO.

Liver Int. 2018 Jan;38(1):84-93. doi: 10.1111/liv.13497. Epub 2017 Jul 7.

PMID:
28622450
34.

Determinants of sleep behavior in adolescents: A pilot study.

Gruber R, Somerville G, Paquin S, Boursier J.

Sleep Health. 2017 Jun;3(3):157-162. doi: 10.1016/j.sleh.2017.03.004. Epub 2017 Apr 8.

PMID:
28526252
35.

Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance.

Aubé C, Bazeries P, Lebigot J, Cartier V, Boursier J.

Diagn Interv Imaging. 2017 Jun;98(6):455-468. doi: 10.1016/j.diii.2017.03.003. Epub 2017 Apr 29. Review.

36.

Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C - authors' reply.

Calès P, Boursier J.

Aliment Pharmacol Ther. 2017 May;45(9):1276-1277. doi: 10.1111/apt.14032. No abstract available.

37.

Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C.

Chindamo MC, Boursier J, Luiz RR, Fouchard-Hubert I, Pannain VL, de Araújo Neto JM, Coelho HS, de Mello Perez R, Calès P, Villela-Nogueira CA.

World J Hepatol. 2017 Feb 28;9(6):310-317. doi: 10.4254/wjh.v9.i6.310.

38.

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Calès P, Boursier J, Lebigot J, de Ledinghen V, Aubé C, Hubert I, Oberti F.

Aliment Pharmacol Ther. 2017 Apr;45(7):991-1003. doi: 10.1111/apt.13954. Epub 2017 Feb 6.

39.

A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.

Boursier J, de Ledinghen V, Leroy V, Anty R, Francque S, Salmon D, Lannes A, Bertrais S, Oberti F, Fouchard-Hubert I, Calès P.

J Hepatol. 2017 Jun;66(6):1158-1165. doi: 10.1016/j.jhep.2017.01.003. Epub 2017 Jan 12.

PMID:
28088581
40.

Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.

Bertrais S, Boursier J, Ducancelle A, Oberti F, Fouchard-Hubert I, Moal V, Calès P.

J Gastroenterol Hepatol. 2017 Jun;32(6):1240-1249. doi: 10.1111/jgh.13668.

PMID:
27897323
41.

Different precore/core mutations of hepatitis B interact with, limit, or favor liver fibrosis severity.

Ducancelle A, Pivert A, Bertrais S, Boursier J, Balan V, Veillon P, le Guillou-Guillemette H, Thibault V, Castelain S, Roquebert B, Coste-Burel M, Mackiewicz V, Schvoerer E, Larrat S, Maylin S, Alain S, Loustaud-Ratti V, Gordien E, Gozlan J, Brodard V, Chevaliez S, Calès P, Lunel-Fabiani F.

J Gastroenterol Hepatol. 2016 Oct;31(10):1750-1756. doi: 10.1111/jgh.13338.

PMID:
26992056
42.

Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury.

Trzepizur W, Boursier J, Mansour Y, Le Vaillant M, Chollet S, Pigeanne T, Bizieux-Thaminy A, Humeau MP, Alizon C, Goupil F, Meslier N, Priou P, Calès P, Gagnadoux F; Institut de Recherche en Santé Respiratoire des Pays de la Loire Sleep Cohort Group.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1657-1661. doi: 10.1016/j.cgh.2016.04.037. Epub 2016 May 5.

PMID:
27155555
43.

Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis?

Deuffic-Burban S, Boursier J, Leroy V, Yazdanpanah Y, Castera L, Mathurin P.

J Hepatol. 2017 Feb;66(2):304-312. doi: 10.1016/j.jhep.2016.10.006. Epub 2016 Oct 13.

PMID:
27743987
44.

Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.

Hocquelet A, Aubé C, Rode A, Cartier V, Sutter O, Manichon AF, Boursier J, N'kontchou G, Merle P, Blanc JF, Trillaud H, Seror O.

J Hepatol. 2017 Jan;66(1):67-74. doi: 10.1016/j.jhep.2016.07.010. Epub 2016 Jul 13.

PMID:
27422750
45.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Boursier J, Vergniol J, Guillet A, Hiriart JB, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-Hubert I, Rousselet MC, Calès P, de Lédinghen V.

J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2.

PMID:
27151181
46.

Nonalcoholic Fatty Liver Disease and the Gut Microbiome.

Boursier J, Diehl AM.

Clin Liver Dis. 2016 May;20(2):263-75. doi: 10.1016/j.cld.2015.10.012. Epub 2015 Dec 24. Review.

PMID:
27063268
47.

Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults.

Monseu M, Dubois S, Boursier J, Aubé C, Gagnadoux F, Lefthériotis G, Ducluzeau PH.

Diabetes Metab. 2016 Nov;42(5):364-367. doi: 10.1016/j.diabet.2016.02.004. Epub 2016 Mar 24.

PMID:
27016890
48.

Reply.

Boursier J, Barret M, Diehl AM.

Hepatology. 2016 Sep;64(3):994-5. doi: 10.1002/hep.28562. Epub 2016 Apr 18. No abstract available.

49.

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.

Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero-Gomez M, Boursier J, Abdelmalek M, Caldwell S, Drenth J, Anstee QM, Hum D, Hanf R, Roudot A, Megnien S, Staels B, Sanyal A; GOLDEN-505 Investigator Study Group.

Gastroenterology. 2016 May;150(5):1147-1159.e5. doi: 10.1053/j.gastro.2016.01.038. Epub 2016 Feb 11. Erratum in: Gastroenterology. 2017 Jun;152(8):2084.

50.

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.

Cassinotto C, Boursier J, de Lédinghen V, Lebigot J, Lapuyade B, Cales P, Hiriart JB, Michalak S, Bail BL, Cartier V, Mouries A, Oberti F, Fouchard-Hubert I, Vergniol J, Aubé C.

Hepatology. 2016 Jun;63(6):1817-27. doi: 10.1002/hep.28394. Epub 2016 Jan 22.

PMID:
26659452

Supplemental Content

Loading ...
Support Center